Cohort study analyzes prescription fills and out-of-pocket costs for glucagon-like peptide-1 receptor agonists, indicating disparities by race and indication.
Key Points
Out-of-pocket costs for glucagon-like peptide-1 receptor agonists varied by race and ethnicity, highlighting disparities in health access.
The study found significant differences in how often prescriptions for these medications were filled, particularly among different racial groups.
A cohort study assessed prescription fulfillment rates and associated costs for patients prescribed glucagon-like peptide-1 receptor agonists.
Health equity may be impacted by race and ethnicity in the utilization of glucagon-like peptide-1 receptor agonists, suggesting a need for targeted interventions.